Skip to main content

Table 3 The levels of total protein (TP), albumin, globulin and albumin/globulin ratio in serum of the control rats and those orally administrated PZA alone, NGN 1 h prior to PZA, and NGN alone, every day for 7, 14, 21 & 28 days. Data are displayed as mean (of 5 rats) ± standard error of mean

From: The protective effect of naringenin against pyrazinamide-induced hepatotoxicity in male Wistar rats

Parameter

Time

(days)

Experimental group

Treatment effect

Control

PZA

PZA + NGN

NGN

TP

(g dL−1)

7

6.58 ± 0.21a

6.83 ± 0.17a

6.74 ± 0.13a

6.57 ± 0.19a

F3, 16 = 0.509, P = 0.681

14

6.53 ± 0.21a

6.72 ± 0.12a

6.88 ± 0.18a

6.86 ± 0.20a

F3, 16 = 0.792, P = 0.516

21

6.61 ± 0.16a

6.95 ± 0.05a

6.88 ± 0.14a

6.86 ± 0.17a

F3, 16 = 1.126, P = 0.368

28

6.80 ± 0.09a

6.67 ± 0.10a

6.69 ± 0.08a

6.86 ± 0.08a

F3, 16 = 0.997, P = 0.419

r

 − 0.11

 − 0.06

 + 0.27

 
 

Time effect

F3, 16 = 0.447, P = 0.723

F3, 16 = 1.056, P = 0.395

F3, 16 = 0.49, P = 0.694

F3, 16 = 0.75, P = 0.538

 

Albumin

(g dL−1)

7

3.72 ± 0.17a

3.69 ± 0.04a

3.56 ± 0.08a

3.58 ± 0.07a

F3, 16 = 0.595, P = 0.627

14

3.77 ± 0.14a

3.67 ± 0.11a

3.68 ± 0.10a

3.63 ± 0.14a

F3, 16 = 0.246, P = 0.863

21

3.72 ± 0.15b

2.99 ± 0.23a*

3.67 ± 0.07b

3.74 ± 0.06b

F3, 16 = 6.326, P = 0.005

28

3.70 ± 0.15b

2.89 ± 0.16a*

3.80 ± 0.05b

3.84 ± 0.09b

F3, 16 = 14.51, P = 0.000

r

 − 0.72

 + 0.46

 + 0.46

 
 

Time effect

F3, 16 = 0.044, P = 0.987

F3, 16 = 8.33, P = 0.001

F3, 16 = 1.704, P = 0.206

F3, 16 = 1.469, P = 0.26

 

Globulin

(g dL−1)

7

2.87 ± 0.09a

3.14 ± 0.13a

3.18 ± 0.06a

2.99 ± 0.12a

F3, 16 = 1.838, P = 0.181

14

2.96 ± 014a

3.05 ± 0.04a

3.20 ± 0.09a

3.23 ± 0.09a

F3, 16 = 1.749, P = 0.197

21

3.09 ± 0.09a

3.76 ± 0.15b*

3.21 ± 0.07a

3.12 ± 0.12a

F3, 16 = 7.94, P = 0.002

28

3.10 ± 0.07a

3.79 ± 0.07b*

3.00 ± 0.10a

3.02 ± 0.01a

F3, 16 = 27.54, P = 0.000

r

 + 0.74

 − 0.31

 − 0.01

 
 

Time effect

F3, 16 = 1.199, P = 0.342

F3, 16 = 13.09, P = 0.000

F3, 16 = 1.303, P = 0.308

F3, 16 = 1.348, P = 0.294

 

Albumin /

globulin

(%)

7

1.21 ± 0.04a

1.19 ± 0.04a

1.12 ± 0.02a

1.20 ± 0.03a

F3, 16 = 1.69, P = 0.209

14

1.22 ± 0.03a

1.20 ± 0.04a

1.15 ± 0.02a

1.16 ± 0.03a

F3, 16 = 1.01, P = 0.415

21

1.16 ± 0.01b

0.86 ± 0.08a*

1.15 ± 0.01b

1.20 ± 0.03b

F3, 16 = 12.96, P = 0.000

28

1.20 ± 0.05b

0.77 ± 0.05a*

1.18 ± 0.05b

1.20 ± 0.04b

F3, 16 = 19.27, P = 0.000

r

 − 0.80

 + 0.36

 + 0.03

 
 

Time effect

F3, 16 = 0.411, P = 0.748

F3, 16 = 15.91, P = 0.000

F3, 16 = 0.952, P = 0.439

F3, 16 = 0.351, P = 0.789

 
  1. P < 0.05, P < 0.01, P < 0.000: represents significant effects. *: represent significant (P < 0.05) differences as compared to 7th day
  2. r: Pearson’s correlation coefficient of the studied parameters with the experimental time
  3. In the same row, according to Duncan’s test, means marked with the same small superscript letters are insignificantly different (P > 0.05), whereas those marked with different ones are significantly different (P < 0.05)